Have your say on the draft of the National Asthma Strategy
After six months of intensive work with the Australian asthma community's best minds, the first draft of the National Asthma Strategy is now complete and ready for your feedback.
We are asking anyone with an interest in asthma to have their say on a plan that will shape how Australia tackles asthma until 2020. This feedback will help us fine tune and finalise the strategy before publication in 2016.
Australia's first National Allergy Strategy launched
Our colleagues at the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy and Anaphylaxis Australia (A&AA) launched Australia's first National Allergy Strategy this month.
The Strategy aims to take a national, policy-driven approach to improve the quality of life of patients, carers and consumers impacted by allergy.
The launch coincided with the formation of the Parliamentary Allergy Alliance (PAA) with an event at Parliament House, Canberra, attended by the Minister for Health, the Hon Sussan Ley MP, the Shadow Minister for Health, The Hon Catherine King MP and the leader of the Australian Greens, Senator Richard Di Natale.
Congratulations to our asthma research award winners at PSA15
We were delighted to attend the Pharmaceutical Society of Australia's PSA15 National Conference earlier this month and appreciated the fantastic response to our dedicated asthma sessions.
Awarded for the very first time this year, the Pharmaceutical Society of Australia and National Asthma Council Australia Asthma Prize is awarded to the best presentation (oral or poster) on asthma at the conference.
This year's prize was awarded to Assoc. Prof. Sinthia Bosnic-Anticevich for her presentation based on research to identify opportunities for pharmacists to intervene in the management of respiratory illness in the community.
A big congratulations to Prof. Bosnic-Anticevich and her team, the Quality Use of Medicines in Respiratory Illness research group at the Woolcock Institute of Medical Research.
'Spirometry driving license' not favoured by ANZRS stakeholders
The Australian and New Zealand Society of Respiratory Science (ANZRS) has released a 'Decision and summary of feedback' report in response to their 2013 proposal to introduce a 'spirometry driving license' and related certification program in our region.
Based on a survey of individual and organisational stakeholders, the report concluded that the adoption of a model based on the European Respiratory Society's licensing system was not favoured.
Results from the survey indicated divided opinion on the expertise required to perform spirometry and a view that not everyone performing spirometry believes it requires the same rigour as a respiratory laboratory procedure. Cost, time and recognition of required standards were seen as major barriers to adopting a single spirometry training approach.
The RACGP representative on our Board, Prof. Bastian Seidel, was featured in Medical Observer this week, responding to comments on one of the innovative proposals of the draft National Asthma Strategy.
In response to reader feedback, Prof. Seidel defended the proposed trial of supplying over-the counter inhaled corticosteroids (ICS), underlining the increasing importance of self-management and advocating a more pragmatic approach.
“The status quo is not going to cut it. We have avoidable asthma deaths and we need to find ways to reduce them.”